Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

What Is the Role of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade in Patients with Metastatic Melanoma?

April 26, 2017antigen blockade cytotoxic melanoma metastatic Patients t

0

Posted

What Is the Role of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade in Patients with Metastatic Melanoma?

1 Answer

0

Posted

Caroline Roberta, Francois Ghiringhellib aInstitute Gustave Roussy, Villejuif, France; bDepartment of Oncology, Dijon Hospital, Dijon, France Key Words. Cytotoxic T lymphocyte–associated antigen 4 • Melanoma • Metastasis • Biomarkers Correspondence: Correspondence: Caroline Robert, M.D., Ph.D., Dermatology Unit, Institute Gustave Roussy, 39 Rue Camille Desmoulins, 94805 Villejuif Cedex, France.